Loading
New surgical tools, imaging probes and radiotherapy hardware invented in universities rarely attract investors. A dedicated fund would pay for prototyping, safety testing and first-in-human studies.
A fund for academic devices and techniques in cancer surgery and radiotherapy: intraoperative imaging probes, margin-assessment tools, low-cost brachytherapy applicators, FLASH-capable beam systems, adaptive planning software, robotic instruments. It pays for design-for-manufacture, ISO 13485 quality systems, biocompatibility and safety testing and IDEAL-framework early studies. Device venture capital is thin outside cardiology and orthopaedics, and academic engineering groups have no path to first-in-human without it. The fund would work with translational institutes and the surgical and radiotherapy trials networks proposed elsewhere in this wave.
Shares Optical & fluorescence imaging, Fluorescence-guided surgery, Surgery and radiotherapy cure most, get least.
Shares FLASH radiotherapy, Brachytherapy.
Shares Mandatory staged registries for new surgical techniques before wide adoption, Fluorescence-guided surgery, Surgery and radiotherapy cure most, get least.
Shares Mandatory staged registries for new surgical techniques before wide adoption, A permanently funded international network for randomised cancer surgery trials, Surgery and radiotherapy cure most, get least.
Shares Translational research: crossing the valley of death, The valley of death between lab and product.
Shares Optical & fluorescence imaging, Fluorescence-guided surgery.
Shares Optical & fluorescence imaging, Fluorescence-guided surgery.
Shares Mandatory staged registries for new surgical techniques before wide adoption, A permanently funded international network for randomised cancer surgery trials, Surgery and radiotherapy cure most, get least.